521 related articles for article (PubMed ID: 31486525)
41. Knowledge, attitude and practice of Malaysian healthcare professionals toward adverse drug reaction reporting: a systematic review.
Balan S
Int J Pharm Pract; 2021 Aug; 29(4):308-320. PubMed ID: 34289016
[TBL] [Abstract][Full Text] [Related]
42. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
43. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Matos C; van Hunsel F; Joaquim J
Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
[TBL] [Abstract][Full Text] [Related]
44. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
Vessal G; Mardani Z; Mollai M
Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
[TBL] [Abstract][Full Text] [Related]
45. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital.
Pimpalkhute SA; Jaiswal KM; Sontakke SD; Bajait CS; Gaikwad A
Indian J Med Sci; 2012; 66(3-4):55-61. PubMed ID: 23603621
[TBL] [Abstract][Full Text] [Related]
47. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
[TBL] [Abstract][Full Text] [Related]
48. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
[TBL] [Abstract][Full Text] [Related]
49. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
[TBL] [Abstract][Full Text] [Related]
50. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital.
Shrestha S; Sharma S; Bhasima R; Kunwor P; Adhikari B; Sapkota B
BMC Med Educ; 2020 Jun; 20(1):179. PubMed ID: 32493307
[TBL] [Abstract][Full Text] [Related]
51. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
52. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
Oosterhuis I; van Hunsel FP; van Puijenbroek EP
Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
[TBL] [Abstract][Full Text] [Related]
53. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
[TBL] [Abstract][Full Text] [Related]
54. A Systematic Review of Healthcare Professionals' Knowledge, Attitudes, and Practices Regarding Adverse Drug Reaction Reporting in Ethiopia.
Anbeo ZG; Abacıoğlu N
Turk J Pharm Sci; 2023 Jul; 20(3):198-209. PubMed ID: 37417202
[TBL] [Abstract][Full Text] [Related]
55. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework.
Li R; Curtis K; Van C; Tabish Razi Zaidi S; Yeo CY; Arun Kali C; Zaheen M; Therese Moujalli G; Castelino R
Eur J Clin Pharmacol; 2022 Jul; 78(7):1165-1175. PubMed ID: 35476123
[TBL] [Abstract][Full Text] [Related]
56. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
[TBL] [Abstract][Full Text] [Related]
57. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal.
Santosh KC; Tragulpiankit P; Edwards IR; Gorsanan S
Int J Risk Saf Med; 2013 Jan; 25(1):1-16. PubMed ID: 23442293
[TBL] [Abstract][Full Text] [Related]
58. Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting.
Aung AK; Tang MJ; Adler NR; de Menezes SL; Goh MSY; Tee HW; Trubiano JA; Puy R; Zubrinich CM; Graudins LV
J Clin Pharmacol; 2018 Oct; 58(10):1332-1339. PubMed ID: 29733431
[TBL] [Abstract][Full Text] [Related]
59. Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists.
Yu YM; Lee E; Koo BS; Jeong KH; Choi KH; Kang LK; Lee MS; Choi KH; Oh JM; Shin WG
PLoS One; 2016; 11(5):e0155517. PubMed ID: 27192159
[TBL] [Abstract][Full Text] [Related]
60. A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective.
Hussain R; Hassali MA; Ur Rehman A; Muneswarao J; Atif M; Babar ZU
Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32349339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
